Zota Health Care LImited (ZOTA) — Financial Results

📢 Key Event
Zota Health Care reported FY26 revenue of INR 53,865 lakhs, up 83.86% YoY, with EBITDA at INR 2,597 lakhs and plans for 500-700 new stores in FY27.

🔄 What Changed
EBITDA turned positive at INR 2,597 lakhs from negative in FY25; same-store growth of 24% for mature stores; 997 new stores added in FY26; gross margin stable at 60.28%.

🔮 What's Next
500-700 store additions planned for FY27; 80-90% of new stores to be COCO format; focus on store-level profitability and same-store growth.

💡 Investor Takeaway
Shareholders should note that Zota is scaling its retail footprint profitably, with strong same-store growth and positive EBITDA signaling improved operational efficiency and sustainable expansion.

Zota Health Care Limited reported FY26 revenue of INR 53,865 lakhs, up 83.86% YoY, driven by Davaindia's expansion to 2,579 stores with 997 new openings, contributing 77% of revenue. Gross margin stood at 60.28%, and EBITDA turned positive at INR 2,597 lakhs. Management highlighted 24% same-store growth for mature stores and plans to add 500-700 stores in FY27, targeting 80-90% COCO format. Footfall reached 182 lakhs with GMV of INR 45,706 lakhs. The company emphasized store-level profitability and sustainable expansion to enhance affordable healthcare access across urban and rural India.

📄 View Original Announcement (PDF)

📊 Stock Analysis — ZOTA ✨ Ask AI About This